Posts

GSK's functional cure data for hepatitis B drug bepirovirsen are a major leap over standard of care

on

FDA Accepts BridgeBio’s NDA for BBP‑418 as Potential First Limb‑Girdle Muscular Dystrophy Treatment

on

FDA Breakthrough Designations Lead to Priority Reviews, Report Finds

on

FDA Announces First Recipients of Makary’s National Priority Voucher Program, Expanding Scope for Accelerated Drug Reviews

on

FDA Grants Dupixent (Dupilumab) Eighth Approval: Now Cleared for Bullous Pemphigoid

on

Bavarian Nordic Sells FDA Priority Review Voucher for $160M Amid Rising Industry Prices and Program Scrutiny

on

FDA Launches New Priority Review Voucher Program Aligned with National Priorities

on

Otsuka's Phase 3 IgAN Win with Sibeprenlimab Shakes Vera's Stock

on